Correspondingly, PKC isoforms have been shown to be activated in NSCLC cells, and to correlate with tumour progression in different cancers (Shipp et al, 2002; Clark et al, 2003; Ali et al, 2009; Gokmen-Polar et al, 2001). The gene discussed is PRRT2; the disease is non-small cell lung carcinoma.